United States Biotechnology & Medical Research

Mirati Therapeutics Inc (MRTX)

Track

Ticker: MRTX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Mirati Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 16 Jan 2024
Value US$843,749.73 | Price 359.25 | Shares 37,815 (-44.9%)
Sale 16 Jan 2024
Value US$1,409,119.27 | Price 428.36 | Shares 93,998 (+0.7%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-18 2024-01-16 S Sale
Christensen Jamie

EVP & Chief Scientific Officer

Officer
37,815 -44.9%
359.25
US$843,750 		37,815 -44.9% 359.25 US$843,750
2024-01-18 2024-01-16 S Sale
Christensen Jamie

EVP & Chief Scientific Officer

Officer
93,998 +0.7%
428.36
US$1,409,119 		93,998 +0.7% 428.36 US$1,409,119
2024-01-18 2024-01-16 S Sale
Hickey Benjamin

EVP, Chief Commercial Officer

Officer
4,507 +11.2%
76.07
US$1,100,700 		4,507 +11.2% 76.07 US$1,100,700
2024-01-18 2024-01-16 S Sale
Hickey Benjamin

EVP, Chief Commercial Officer

Officer
966 -0.8%
59.02
US$57,013 		966 -0.8% 59.02 US$57,013
2024-01-09 2024-01-08 S Sale
Hickey Benjamin

EVP, Chief Commercial Officer

Officer
2,090 -1.7%
58.92
US$123,143 		2,090 -1.7% 58.92 US$123,143
2024-01-05 2024-01-04 S Sale
Christensen Jamie

EVP & Chief Scientific Officer

Officer
1,531 -1.0%
58.81
US$90,038 		1,531 -1.0% 58.81 US$90,038
2023-12-19 2023-12-18 S Sale
Christensen Jamie

EVP & Chief Scientific Officer

Officer
2,387 -1.7%
57.50
US$137,252 		2,387 -1.7% 57.50 US$137,252
2023-12-14 2023-12-13 S Sale
Hickey Benjamin

EVP, Chief Commercial Officer

Officer
2,220 -2.1%
56.67
US$125,807 		2,220 -2.1% 56.67 US$125,807
2023-09-12 2023-09-08 S Sale
Christensen Jamie

EVP & Chief Scientific Officer

Officer
2,388 -1.6%
35.63
US$85,084 		2,388 -1.6% 35.63 US$85,084
2023-08-15 2023-08-11 B Purchase
3.6
Boxer Capital, LLC

See remarks
1,201,440 +60.1%
27.80
US$33,400,032 		1,201,440 +60.1% 27.80 US$33,400,032
2023-08-15 2023-08-11 B Purchase
3.6
Boxer Capital, LLC

See remarks
57,533 +25.0%
27.80
US$1,599,417 		57,533 +25.0% 27.80 US$1,599,417
2023-08-15 2023-08-11 B Purchase
3.6
Boxer Capital, LLC

See remarks
1,201,440 +60.1%
27.80
US$33,400,032 		1,201,440 +60.1% 27.80 US$33,400,032
2023-08-15 2023-08-11 B Purchase
3.6
Boxer Capital, LLC

See remarks
57,533 +25.0%
27.80
US$1,599,417 		57,533 +25.0% 27.80 US$1,599,417
2023-08-14 2023-08-11 B Purchase
2.7
Hasnain Faheem
Non-Executive Director
10,791 +inf%
27.80
US$299,990 		10,791 +inf% 27.80 US$299,990
2023-06-02 2023-06-02 S Sale
Stelzer Laurie

Chief Financial Officer

Officer
4,647 -5.5%
37.06
US$172,218 		4,647 -5.5% 37.06 US$172,218
2023-05-24 2023-05-24 S Sale
Christensen Jamie

EVP & Chief Scientific Officer

Officer
619 -0.5%
45.29
US$28,035 		619 -0.5% 45.29 US$28,035
2023-01-20 2023-01-18 PlS Planned sale
3.1
Cherrington Julie M
Non-Executive Director
2,546 -100.0%
44.66
US$113,704 		2,546 -100.0% 44.66 US$113,704
2023-01-19 2023-01-17 S Sale
2.8
Meek David D.

Chief Executive Officer

Executive Director
3,179 -4.9%
42.38
US$134,715 		3,179 -4.9% 42.38 US$134,715
2023-01-19 2023-01-17 S Sale
Hickey Benjamin

EVP, Chief Commercial Officer

Officer
619 -1.3%
42.38
US$26,234 		619 -1.3% 42.38 US$26,234
2023-01-19 2023-01-17 S Sale
Hickey Benjamin

EVP, Chief Commercial Officer

Officer
947 -1.9%
42.38
US$40,132 		947 -1.9% 42.38 US$40,132
2023-01-19 2023-01-17 S Sale
Christensen Jamie

EVP, Chief Scientific Officer

Officer
887 -0.9%
42.38
US$37,593 		887 -0.9% 42.38 US$37,593
2023-01-19 2023-01-17 S Sale
Christensen Jamie

EVP, Chief Scientific Officer

Officer
1,358 -1.4%
42.38
US$57,549 		1,358 -1.4% 42.38 US$57,549
2023-01-10 2023-01-09 S Sale
Hickey Benjamin

EVP, Chief Commercial Officer

Officer
2,088 -4.1%
45.37
US$94,733 		2,088 -4.1% 45.37 US$94,733
2023-01-05 2023-01-04 S Sale
BAUM CHARLES M

President,Founder,Head of R&D

Executive Director
3,648 -2.1%
46.60
US$169,997 		3,648 -2.1% 46.60 US$169,997
2023-01-05 2023-01-04 S Sale
Christensen Jamie

EVP, Chief Scientific Officer

Officer
1,949 -1.9%
46.60
US$90,823 		1,949 -1.9% 46.60 US$90,823
2022-12-21 2022-12-21 S Sale
BAUM CHARLES M

President,Founder,Head of R&D

Executive Director
9,092 -5.0%
40.42
US$367,469 		9,092 -5.0% 40.42 US$367,469
2022-12-21 2022-12-21 S Sale
2.8
Meek David D.

Chief Executive Officer

Executive Director
4,616 -6.6%
40.41
US$186,552 		4,616 -6.6% 40.41 US$186,552
2022-12-21 2022-12-21 S Sale
Hickey Benjamin

EVP, Chief Commercial Officer

Officer
3,248 -6.0%
40.41
US$131,266 		3,248 -6.0% 40.41 US$131,266
2022-12-20 2022-12-16 S Sale
Christensen Jamie

EVP, Chief Scientific Officer

Officer
2,410 -2.3%
43.00
US$103,624 		2,410 -2.3% 43.00 US$103,624
2022-12-05 2022-12-02 S Sale
Christensen Jamie

EVP, Chief Scientific Officer

Officer
1,726 -1.6%
90.19
US$155,667 		1,726 -1.6% 90.19 US$155,667
2022-11-28 2022-11-28 PlS Planned sale
BAUM CHARLES M

President,Founder,Head of R&D

Executive Director
69,256 -35.1%
100.00
US$6,925,600 		69,256 -35.1% 100.00 US$6,925,600
2022-08-16 2022-08-12 S Sale
2.6
CARTER BRUCE L A
Non-Executive Director
4,893 -44.8%
85.96
US$420,612 		4,893 -44.8% 85.96 US$420,612
2022-08-16 2022-08-12 S Sale
2.6
CARTER BRUCE L A
Non-Executive Director
5,107 -31.9%
85.04
US$434,287 		5,107 -31.9% 85.04 US$434,287
2022-06-14 2022-05-23 S Sale
Christensen Jamie

EVP, Chief Scientific Officer

Officer
624 -0.7%
63.54
US$39,649 		624 -0.7% 63.54 US$39,649
2022-02-14 2022-02-11 PlS Planned sale
2.5
FUCHS HENRY J
Non-Executive Director
210 -3.4%
106.34
US$22,332 		210 -3.4% 106.34 US$22,332
2022-02-14 2022-02-11 PlS Planned sale
2.5
FUCHS HENRY J
Non-Executive Director
8,700 -58.3%
105.80
US$920,428 		8,700 -58.3% 105.80 US$920,428
2022-02-14 2022-02-11 PlS Planned sale
2.5
FUCHS HENRY J
Non-Executive Director
2,090 -12.3%
104.76
US$218,958 		2,090 -12.3% 104.76 US$218,958
2022-01-20 2022-01-19 PlS Planned sale
3.1
Cherrington Julie M
Non-Executive Director
1,475 -36.7%
116.07
US$171,203 		1,475 -36.7% 116.07 US$171,203
2022-01-18 2022-01-18 S Sale
BAUM CHARLES M

President,Founder,Head of R&D

Executive Director
2,517 -1.9%
120.48
US$303,253 		2,517 -1.9% 120.48 US$303,253
2022-01-18 2022-01-18 S Sale
Hickey Benjamin

EVP, Chief Commercial Officer

Officer
627 -1.8%
120.48
US$75,543 		627 -1.8% 120.48 US$75,543
2022-01-18 2022-01-18 S Sale
REED VICKIE S

SVP, Chief Accounting Officer

Officer
533 -3.4%
120.48
US$64,217 		533 -3.4% 120.48 US$64,217
2022-01-18 2022-01-18 S Sale
Christensen Jamie

EVP, Chief Scientific Officer

Officer
627 -0.7%
120.51
US$75,558 		627 -0.7% 120.51 US$75,558
2022-01-07 2022-01-07 S Sale
Hickey Benjamin

EVP, Chief Commercial Officer

Officer
1,964 -7.3%
135.94
US$266,984 		1,964 -7.3% 135.94 US$266,984
2022-01-07 2022-01-07 S Sale
REED VICKIE S

SVP, Chief Accounting Officer

Officer
345 -3.2%
135.94
US$46,900 		345 -3.2% 135.94 US$46,900
2022-01-06 2022-01-04 S Sale
Christensen Jamie

EVP, Chief Scientific Officer

Officer
1,442 -1.8%
147.72
US$213,017 		1,442 -1.8% 147.72 US$213,017
2022-01-06 2022-01-04 S Sale
REED VICKIE S

SVP, Chief Accounting Officer

Officer
758 -6.5%
147.74
US$111,987 		758 -6.5% 147.74 US$111,987
2022-01-06 2022-01-04 S Sale
BAUM CHARLES M

President,Founder,Head of R&D

Executive Director
69 -0.1%
149.09
US$10,287 		69 -0.1% 149.09 US$10,287
2022-01-06 2022-01-04 S Sale
BAUM CHARLES M

President,Founder,Head of R&D

Executive Director
4,045 -3.8%
147.73
US$597,568 		4,045 -3.8% 147.73 US$597,568
2021-12-07 2021-12-06 S Sale
Christensen Jamie

EVP, Chief Scientific Officer

Officer
9 -0.0%
132.00
US$1,188 		9 -0.0% 132.00 US$1,188
2021-12-07 2021-12-06 S Sale
Christensen Jamie

EVP, Chief Scientific Officer

Officer
1,192 -2.0%
130.78
US$155,890 		1,192 -2.0% 130.78 US$155,890
2021-12-03 2021-12-03 PlS Planned sale
BAUM CHARLES M

President & Head of R&D

Executive Director
985 -0.9%
137.56
US$135,495 		985 -0.9% 137.56 US$135,495
2021-12-03 2021-12-03 PlS Planned sale
BAUM CHARLES M

President & Head of R&D

Executive Director
1,210 -1.1%
136.66
US$165,361 		1,210 -1.1% 136.66 US$165,361
2021-12-03 2021-12-03 PlS Planned sale
BAUM CHARLES M

President & Head of R&D

Executive Director
6,558 -5.4%
135.64
US$889,539 		6,558 -5.4% 135.64 US$889,539
2021-12-03 2021-12-03 PlS Planned sale
BAUM CHARLES M

President & Head of R&D

Executive Director
3,842 -3.1%
134.57
US$517,023 		3,842 -3.1% 134.57 US$517,023
2021-12-03 2021-12-03 PlS Planned sale
BAUM CHARLES M

President & Head of R&D

Executive Director
3,900 -3.0%
133.27
US$519,744 		3,900 -3.0% 133.27 US$519,744
2021-12-03 2021-12-03 PlS Planned sale
BAUM CHARLES M

President & Head of R&D

Executive Director
21,509 -14.3%
132.49
US$2,849,721 		21,509 -14.3% 132.49 US$2,849,721
2021-12-03 2021-12-03 PlS Planned sale
BAUM CHARLES M

President & Head of R&D

Executive Director
9,200 -5.8%
131.61
US$1,210,804 		9,200 -5.8% 131.61 US$1,210,804
2021-06-21 2021-06-18 PlS Planned sale
BAUM CHARLES M

President & CEO

Executive Director
1,023 -0.9%
166.73
US$170,566 		1,023 -0.9% 166.73 US$170,566
2021-06-21 2021-06-18 PlS Planned sale
BAUM CHARLES M

President & CEO

Executive Director
20,823 -15.5%
166.07
US$3,457,986 		20,823 -15.5% 166.07 US$3,457,986
2021-06-21 2021-06-18 PlS Planned sale
BAUM CHARLES M

President & CEO

Executive Director
13,338 -9.0%
164.90
US$2,199,499 		13,338 -9.0% 164.90 US$2,199,499
2021-06-21 2021-06-18 PlS Planned sale
BAUM CHARLES M

President & CEO

Executive Director
4,816 -3.2%
164.07
US$790,182 		4,816 -3.2% 164.07 US$790,182
2021-05-25 2021-05-24 S Sale
Christensen Jamie

EVP, Chief Scientific Officer

Officer
435 -0.8%
154.34
US$67,138 		435 -0.8% 154.34 US$67,138
2021-04-06 2021-04-05 PlS Planned sale
2.6
CARTER BRUCE L A
Non-Executive Director
282 -7.5%
180.00
US$50,760 		282 -7.5% 180.00 US$50,760
2021-04-06 2021-04-05 PlS Planned sale
2.6
CARTER BRUCE L A
Non-Executive Director
1,968 -34.4%
176.70
US$347,747 		1,968 -34.4% 176.70 US$347,747
2021-03-22 2021-03-19 PlS Planned sale
Hickey Benjamin

EVP, Chief Commercial Officer

Officer
431 -1.6%
177.71
US$76,591 		431 -1.6% 177.71 US$76,591
2021-03-22 2021-03-19 PlS Planned sale
Hickey Benjamin

EVP, Chief Commercial Officer

Officer
1,350 -4.7%
176.42
US$238,171 		1,350 -4.7% 176.42 US$238,171
2021-03-22 2021-03-19 PlS Planned sale
Hickey Benjamin

EVP, Chief Commercial Officer

Officer
588 -2.0%
175.54
US$103,216 		588 -2.0% 175.54 US$103,216
2021-03-10 2021-03-10 S Sale
3.0
Braslyn Ltd.
Large shareholder
1 -0.0%
195.90
US$196 		1 -0.0% 195.90 US$196
2021-03-10 2021-03-10 S Sale
3.0
Braslyn Ltd.
Large shareholder
200 -0.0%
198.00
US$39,600 		200 -0.0% 198.00 US$39,600
2021-03-10 2021-03-10 S Sale
3.0
Braslyn Ltd.
Large shareholder
20 -0.0%
196.12
US$3,922 		20 -0.0% 196.12 US$3,922
2021-03-10 2021-03-10 S Sale
3.0
Braslyn Ltd.
Large shareholder
189 -0.0%
195.52
US$36,953 		189 -0.0% 195.52 US$36,953
2021-03-10 2021-03-09 S Sale
3.0
Braslyn Ltd.
Large shareholder
1 -0.0%
191.00
US$191 		1 -0.0% 191.00 US$191
2021-03-10 2021-03-09 S Sale
3.0
Braslyn Ltd.
Large shareholder
2,237 -0.1%
199.08
US$445,342 		2,237 -0.1% 199.08 US$445,342
2021-03-10 2021-03-09 S Sale
3.0
Braslyn Ltd.
Large shareholder
3,993 -0.1%
197.81
US$789,855 		3,993 -0.1% 197.81 US$789,855
2021-03-10 2021-03-09 S Sale
3.0
Braslyn Ltd.
Large shareholder
4,633 -0.1%
197.30
US$914,091 		4,633 -0.1% 197.30 US$914,091
Explore more

More insider trading research around Mirati Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America